BAJAJ BROKING

Notification
No new Notification messages
Suraksha Diagnostic IPO is Open!
Apply for the Suraksha Diagnostic IPO through UPI in just minutes.
Open a Free Demat Account
Pay ZERO maintenance charges for the first year, get free stock picks daily, and more.
Q2 FY'24-25 Results of Top Companies
Reliance, TCS, HDFC Bank & more: Explore key financial highlights from India's top quarterly results.
Trade Now, Pay Later with up to 4x
Never miss a good trading opportunity due to low funds with our MTF feature.
Track Market Movers Instantly
Stay updated with real-time data. Get insights at your fingertips.

Suraksha Diagnostic Ltd

Healthcare

Offer Period :

29th to 3rd Dec 2024

Suraksha Diagnostic Ltd IPO Details

IPO Date 29th to 3rd Dec 2024 Minimum Investment ₹14994 / 1 Lots
Listing Date 2024-12-06 Maximum Investment ₹194922 / 13 Lots
Face Value ₹2 per share Total Issue Size ₹846.25 Crores
Price ₹420 to ₹441 per share Fresh Issue ₹0 Crores
Lot Size 1 Lots (34 Shares) Offer For Sale ₹ 846.25
Listing At BSE, NSE Retail Discount ₹ 0
Employee Discount ₹0 per share    
IPO Date 29th to 3rd Dec 2024
Listing Date 2024-12-06
Face Value ₹2 per share
Price ₹420 to ₹441 per share
Lot Size 1 Lots (34 Shares)
Listing At BSE, NSE
Employee Discount ₹0 per share
Minimum Investment ₹14994 / 1 Lots
Maximum Investment ₹194922 / 13 Lots
Total Issue Size ₹846.25 Crores
Fresh Issue ₹0 Crores
Offer For Sale
Retail Discount ₹ 0

About Suraksha Diagnostic Limited

Suraksha Diagnostic Limited, incorporated in 2005, specializes in pathology, radiology, and medical consultancy services. With a central reference lab, eight satellite labs, and 215 customer touchpoints - including 49 diagnostic centers and 166 sample collection centers - it operates across West Bengal, Bihar, Assam, and Meghalaya as of June 30, 2024. The company offers integrated online and offline consultation services through 44 diagnostic centers, housing 120 polyclinics staffed by over 750 doctors. Advanced technology platforms like LIMS, RIS, PACS, and ERP optimize operations, while digital pathology and AI enhance diagnostic accuracy. Radiology reports are delivered via a unified digital platform, reducing turnaround times. 

 

Key strengths include a robust presence in Eastern and Northeastern India, integrated services, advanced infrastructure, a commitment to quality, and an experienced management team, positioning Suraksha Diagnostic as a leading player in organized diagnostic services.

Timeline

Important dates for allocation and IPO listing.

29th Nov

IPO Starts

3rd Dec

IPO Ends

4th Dec

Allotment Date

5th Dec

Initiation of Refund

5th Dec

Credit of Shares to Demat Account

6th Dec

IPO Listing Date

Shareholder Pattern

  Pre-Issue Post-Issue
Promoter Group 61.07 48.78
Public Group 38.93 51.22

Suraksha Diagnostic Ltd IPO Reservation

QIB Shares Offered 3837866(20%)
NII (HNI) Shares Offered 2878400(15%)
Retail Shares Offered 6716265(35%)
Anchor Investor Shares Offered 5756799(30%)
Total Shares Offered 19189330
Total Shares With Anchor Investor 19189330

IPO Lot Size

ApplicationLotsSharesAmount
Retail (Min)---
Retail (Max)---
S-HNI (Min)---
S-HNI (Max)---

Suraksha Diagnostic Ltd IPO Registrar

KFin Techologies Ltd
Phone Number +91 40 6716 2222
Email Id einward.ris@kfintech.com
Our Website www.kfintech.com

Suraksha Diagnostic Ltd IPO Lead Manager

1. ICICI Securities Ltd

2. Nuvama Wealth Management Ltd

3. SBI Capital Markets Ltd

Explore IPOs


Explore comprehensive IPO details for every IPO. Access essential information such as listing price, listing date, issue price, lot size, issue size, minimum investment, and IPO timeline. Gain insights into the company's background, strengths, and potential risks. Track the subscription status and delve into the financials of the company, empowering yourself with crucial data for informed investment decisions. Stay ahead in the dynamic IPO market by staying informed on upcoming, ongoing, and past IPOs. 
 

Stay ahead in the ever-evolving IPO landscape with our comprehensive platform. We offer a holistic resource, ensuring you not only access essential details but also gain valuable insights into market trends. Navigate confidently, armed with intricate analyses, expert opinions, and real-time updates. Whether you're a seasoned investor or a novice, our user-friendly interface and extensive information empower you to make well-informed decisions. Experience the convenience of having a dedicated space where you can delve into the intricacies of IPOs, enabling a strategic and calculated approach to the dynamic stock market. 

Suraksha Diagnostic Ltd IPO Subscription LIVE Status

Category No. of shares offered No. of shares bid No. of subscribed
Qualified Institutional Buyers (QIBs) 38,37,867 1,326 1.0
Non Institutional Investors (NIIs) 28,78,400 7,20,120 284.0
Non Institutional Investors (Bid amount of more than Ten Lakh Rupees) 19,18,934 4,29,726 1,14,940.0
Non Institutional Investors (Bid amount of more than Two Lakh and upto Ten Lakh Rupees) 9,59,466 2,90,394 1,14,940.0
Retail Individual Investors (RIIs) 67,16,266 37,77,876 27,716.0
Total 1,34,32,533 44,99,322 1,14,940.0

Strength of Suraksha Diagnostic Ltd

1. Diagnostic chain with in eastern India well positioned to leverage growth opportunity for organized diagnostic chains in the diagnostic services markets in eastern and north-eastern India.

2. Track record of profitability and financial performance.

3. Integrated diagnostics provider with one-stop solution offering pathology and radiology testing, and medical consultation services.

4. Technologically advanced clinical infrastructure and trained personnel providing diagnostic services.

5. Commitment to quality driving high individual consumer business share and customer retention.

6. Management team with relevant industry experience.

Risks Involved

1. 95.48% of its Revenue from Operations in Fiscal 2024 was generated from West Bengal, and any loss of business in such region could have an adverse effect on its business, results of operations and financial condition.

2. The securities of certain of its Promoter Group members have been suspended from trading on a recognized stock exchange in the past. The company cannot assure you that there will be no such instances in the future which may adversely affect its operations, reputation and ability to raise capital through further public issue of securities.

3. The diagnostics industry in India is highly competitive and its inability to compete effectively from other healthcare service providers may adversely affect its business, results of operations and financial condition. Further, as of Financial Year 2024, the market share of the Company in its major market which is East India is 1.15-1.30%.

4. The B2B segment contributed to 6.17% of its Revenue from Operations in Fiscal 2024 and any non-renewal or cancellation of its arrangements with its institutional customers, including hospitals, and Public-Private Partnership ("PPP") contracts may adversely affect its business, results of operations and financial condition.

5. Its Statutory Auditors have included certain emphasis of matters, and audit qualifications matters prescribed in the audit reports of the Company for Fiscals 2023 and 2024.

6. In the past, the company failed to comply with certain provisions of the Companies Act, 2013, and had to compound such non-compliances. The company cannot assure you that there will be no such non-compliances in the future and that the Company, Promoters, or Directors will not be subject to any penalty or additional payment.

7. Certain of its Promoters, Directors, Subsidiaries and Group Company are in businesses similar to its and have interests in certain companies, which are in similar businesses to its, and this may result in potential conflict of interest with the company.

8. Its Promoters and certain members of the company Promoter Group pledged some of the Equity Shares held by them in favour of Vistra ITCL (India) Limited, in its capacity as debenture trustee for the benefit of the debentureholders, as security for debentures issued by its Promoter Group entity, Tinni Investments Limited, and there are disposal restrictions created on Equity Shares held by certain other shareholders. Upon creation, any invocation of such pledge could dilute the aggregate shareholding of its Promoters, and such members of the company Promoter Group, which may cause a change in control of the Company and trigger an open offer requirement under the Takeover Regulations.

9. There are outstanding legal proceedings involving the Company, Subsidiaries, Promoters, Directors and Group Companies which may adversely affect its business, financial condition and results of operations.

10. The Company will not receive any proceeds from the Offer for Sale. The Selling Shareholders will receive the entire net proceeds from the Offer for Sale.

Why should you invest in

-

Financials

Particulars For the financial year ending (in ₹ million)
  2024 2023
Total Assets 300.2 281.19
Total Liabilities 300.2 281.19
Total Expenses 190.03 186.94
Total Revenue 
222.26 193.69
Profit After Tax 23.63 6.52
EBITDA 72.84 47.48
Adjusted EBITDA 0 0

Suraksha Diagnostic Ltd IPO Listing Details

Listing Date BSE Script Code NSE Symbol ISIN Final Issue Price
2024-12-06 0 -
INE877V01027
₹0 per share

Listing Day Trading Information

Price Details BSE NSE
Final Issue Price ₹420 ₹0
Open ₹0 ₹0
Low ₹0 ₹0
High ₹0 ₹0
Low ₹0 ₹0

 Interested in more opportunities? Check out our Upcoming IPO section for new listings and don’t forget to check your IPO allotment status for Suraksha Diagnostic IPO.

Frequently Asked Questions

What is Suraksha Diagnostic Ltd IPO?

Answer Field

Suraksha Diagnostic Ltd IPO is a Mainboard IPO of 1,91,89,330 equity shares of a face value of ₹2 aggregating up to ₹846.25 Crores. The issue is priced at ₹420 to ₹441 per share. The minimum order quantity is 34 Shares. The IPO opens on November 29, 2024, and closes on December 03, 2024. KFin Techologies Ltd is the registrar for the IPO. The shares are proposed to be listed on BSE,NSE.

When Suraksha Diagnostic Ltd IPO will open?

Answer Field

The Suraksha Diagnostic Ltd IPO opens on November 29, 2024 and closes on December 03, 2024.

What is the lot size of Suraksha Diagnostic Ltd?

Answer Field

Suraksha Diagnostic Ltd lot size is 34 shares, and the minimum amount required is ₹14,994.

How to apply for Suraksha Diagnostic Ltd IPO?

Answer Field

You can apply in Suraksha Diagnostic Ltd IPO online using either UPI or ASBA as payment method. ASBA IPO application is available in the net banking of your bank account. UPI IPO application is offered by brokers who don't offer banking services. To apply for an IPO:

• Login to Bajaj Broking account App/Website & click on IPO

• Enter the number of lots and price at which you wish to apply.

• Enter your UPI ID and click on submit. With this, your bid will be placed with the exchange.

• You will receive a mandate notification to block funds in your UPI app.

• Approve the mandate request on your UPI and funds will be blocked.

When is Suraksha Diagnostic Ltd IPO allotment?

Answer Field

The finalization of Basis of Allotment for Suraksha Diagnostic Ltd IPO will be done on December 04, 2024, and the allotted shares will be credited to your demat account by December 05, 2024.

When is Suraksha Diagnostic Ltd IPO listing date?

Answer Field

The Suraksha Diagnostic Ltd listing date is December 06, 2024.

Who is the registrar of Suraksha Diagnostic Ltd IPO?

Answer Field

The registrar of Suraksha Diagnostic Ltd IPO is KFin Techologies Ltd

Which company is the book-running lead manager of the IPO?

Answer Field

ICICI Securities Ltd,Nuvama Wealth Management Ltd,SBI Capital Markets Ltd will be the book-running lead manager of this IPO.

What is the fresh issue of Suraksha Diagnostic Ltd IPO?

Answer Field

The fresh issue size is ₹[-] Crores equity shares.

What minimum lot size can retail subscribers subscribe to Suraksha Diagnostic Ltd?

Answer Field

Retail investors can subscribe to a minimum of one lot, 34 shares and ₹14,994 amount.

How can I approve the UPI mandate request for Suraksha Diagnostic Ltd IPO?

Answer Field

To apply for Suraksha Diagnostic Ltd IPO, you need to log in to your demat account to complete the bidding process. Then, approve the payment mandate on your UPI app.

What is the price range of Suraksha Diagnostic Ltd?

Answer Field

The price of each Suraksha Diagnostic Ltd share will be ranging in between ₹420 to ₹441 per share.

What is the cut-off time for the UPI mandate for Suraksha Diagnostic Ltd IPO?

Answer Field

The cut-off time for the UPI mandate confirmation is 5:00 PM, December 03, 2024.

No results found

Browse IPOs

upcoming-radio
  • IPO Name
  • Bidding Dates
  • Price range
  • IPO Size
  • Lorem Ipsum
current-radio
  • IPO Name
  • Bidding Dates
  • Price range
  • IPO Size
  • Lorem Ipsum
  • SURAKSHA DIAGNOSTIC LIMITEDMainboard IPO

  • Bidding Dates

    29th Nov 2024 - 12th Dec 2024

  • Price Range

    ₹420.0 - 441.0

  • IPO Size

    ₹8,46,25,00,000

  • Apply Now
  • GANESH INFRAWORLD LIMITEDSME IPO

  • Bidding Dates

    29th Nov 2024 - 12th Dec 2024

  • Price Range

    ₹78.0 - 83.0

  • IPO Size

    ₹98,57,00,000

  • Apply Now
closed-radio
  • IPO Name
  • Bidding Dates
  • Price range
  • IPO Size
  • Lorem Ipsum
  • SWIGGY LIMITEDMainboard IPO

  • Bidding Dates

    6th Nov 2024 - 11th Nov 2024

  • Price Range

    ₹371.0 - 390.0

  • IPO Size

    ₹1,13,27,43,00,000

  • Invest Now
performance-radio
  • IPO Name
  • ISSUE PRICE
  • LISTING DAY CLOSE
  • LISTING DAY(GAIN/LOSS)
  • Lorem Ipsum
  • ONYX BIOTEC LIMITEDSME IPO

  • Issue Price

    61.00

  • Listing Day Close

    56.75

  • Listing Day (Gain/Loss)

    -6.56

  • SWIGGY LIMITEDMainboard IPO

  • Issue Price

    390.00

  • Listing Day Close

    455.95

  • Listing Day (Gain/Loss)

    16.92

  • DANISH POWER LIMITEDSME IPO

  • Issue Price

    380.00

  • Listing Day Close

    598.50

  • Listing Day (Gain/Loss)

    57.63

We have something for everyone

Explore more Investment options

Stocks

Secure and enhance your financial future today

investment-card-icon

IPOs

Your gateway to future financial opportunities

investment-card-icon

MTF

Explore Buy Now Pay Later and boost your capital by up to 4x  

investment-card-icon

US Stocks

Discover opportunities to invest in elite FAANG stocks

investment-card-icon

Related Articles

Our Secure Trading Platforms

Level up your stock market experience: Download the Bajaj Broking App for effortless investing and trading

Bajaj Broking App Download

8 Lacs + Users

icon-with-text

4.8+ App Rating

icon-with-text

4 Languages

icon-with-text

₹5000+ Cr MTF Book

icon-with-text